President Donald Trump said his administration is pressuring pharmaceutical companies to break up childhood vaccines into ...
GLP-1 drugs, including Wegovy, Zepbound, and Foundayo, help patients lose weight by mimicking a hormone that makes the body ...
Vera Therapeutics, Inc. ( VERA) reported that in the pivotal ORIGIN 3 trial of TRUTAKNA (atacicept-vymj), an FDA-approved dual BAFF and APRIL inhibitor, it stabilised kidney function and prevented ...
The latest installment in BioPharma Dive’s new visualization-focused series features a stock sell-off that confused Wall ...
Tempus AI (NASDAQ:TEM | TEM Price Prediction) is having a breakout week after Morgan Stanley remarks on September 15 ...
Shinhan Securities says Olix could become big pharma's only ALK7 obesity drug licensing candidate as rivals report first ...
Prime Minister Kretschmer spoke out clearly in the state parliament regarding the pharmaceutical company GSK's plans to close ...
The Department of Health recommends that regional flu vaccination campaigns be launched from the start of October ...
GSK will acquire a trispecific T cell engager for multiple myeloma from Chimagen Biosciences in a deal worth up to $750 ...
Nigeria’s corporate exodus story is now familiar, with ride-hailing app Uber’s September 2nd exit, after twelve years in the market, the latest. Recently, hypermarket giant Shoprite has wound down its ...
William Draper III, who brought Harvard Business School savvy to the earliest stirrings of Silicon Valley as a co-founder ...
GSK trades at GBX1,860.50 today, up 0.4%. Key technicals highlight sideways movement and volatility in the short term.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results